TRIVASTAL

This brand name is authorized in France, Malta, Singapore, Tunisia, Turkey.

Active ingredients

The drug TRIVASTAL contains one active pharmaceutical ingredient (API):

1
UNII DO22K1PRDJ - PIRIBEDIL
 

Piribedil is a dopaminergic agonist (stimulates dopamine receptors and the cerebral dopaminergic pathways).
 
Read more about Piribedil

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 TRIVASTAL Sustained release coated tablet MPI, EU: SmPC Web Search

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
N04BC08 Piribedil N Nervous system → N04 Anti-parkinson drugs → N04B Dopaminergic agents → N04BC Dopamine agonists
Discover more medicines within N04BC08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
FR Base de données publique des médicaments 61598530, 62551633
MT Medicines Authority MA066/01101
SG Health Sciences Authority 09947P
TN Direction de la Pharmacie et du Médicament 6353091
TR İlaç ve Tıbbi Cihaz Kurumu 8699552140122

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈